Why the study?
Mitral annuloplasty rings may fail and cause recurrent mitral regurgitation, making transcatheter mitral valve-in-ring replacement a potential strategy for patients with high surgical risks.
Does transcatheter MViR replacement using a novel Renato valve improve mitral regurgitation and symptoms in a patient with a failed annuloplasty ring and LV dysfunction?
Does transcatheter MViR replacement using a novel Renato valve improve mitral regurgitation and symptoms in a patient with a failed annuloplasty ring and LV dysfunction?
Transcatheter mitral valve-in-ring replacement using a novel Renato valve appears to be a safe and effective strategy for treating severe mitral regurgitation due to a failed annuloplasty ring in a high-surgical-risk patient.
No takes yet. Share an insight, caveat, or question.
Suggests feasibility of novel valve-in-ring replacement in high-risk MR; leaves open need for prospective trials before wider adoption.
Cao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: